p53 protein alterations in adult astrocytic tumors and oligodendrogliomas

Neurology India

Volumn 52, Issue 2, 2004, Pages 228-232

  Nayak, Anupma ^a   Ralte, Angela Mercy ^a   Sharma, Mehar Chand ^a   Sigh, Varinder Paul ^a   Mahapatra, Ashok Kumar ^a   Mehta, Veer Singh ^a   Sarkar, Chitra ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Astrocytoma; Immunohistochemistry; Oligodendroglioma; p53

Indexed keywords

PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; BRAIN REGION; BRAIN STEM; CANCER GRADING; CEREBELLUM; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OLIGODENDROGLIOMA; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; WORLD HEALTH ORGANIZATION; AGED; BRAIN TUMOR; CEREBELLUM TUMOR; CHEMISTRY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INFRATENTORIAL NEOPLASMS; MIDDLE AGED; OLIGODENDROGLIOMA; SUPRATENTORIAL NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 4344624988     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Levine AJ, Momand J, Finlay CA. The p53 tumor suppressor gene. Nature 1991;351:453-6.
2. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science 1991;253:49-53.
3. Fulci G, Ishii N, Van Meir EG. p53 and brain tumors: From gene mutations to gene therapy. Brain Pathol 1998; 8:599-613.
4. Louis DN, von Deimling A, Chung RY, et al. Comparative study of p53 gene and protein alterations in human astrocytic tumors. J Neuropathol Exp Neurol 1993;52:31-8.
5. Newcomb EW, Madonia WJ, Pisharody S, et al. A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme. Brain Pathol 1993;3:229-35.
6. Louis DN. The p53 gene and protein in human brain tumours. J Neuropathol Exp Neurol 1994;53:11-21.
7. Ohgaki H, eibl RH, Schwab M, et al. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Mol Carcinog 1993;8:74-80.
8. Rasheed BKA, McLendon RK, Herndon JD, et al. Alterations of the TP53 gene in human gliomas. Cancer Res 1994;54:1324-30.
9. von Deimling A, eibl RH, Ohgaki H, et al. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 1992;52:2987-90.
10. Chattopadhyay P, Rathore A, Mathur M, et al. Loss of heterozygosity of a locus on independent of p53 is associated with higher grades of astrocytic tumours. Oncogene 1997;15:871-4.
11. Sarkar C, Rathore A, Chattopadhyay P, et al. Role of chromosomal region in determining p53 protein immunopositivity in human astrocytic tumours. Pathology 2000;:32:84-8.
12. Cavenee WK, Funhari FB, Nagane M. Diffusely infiltrating astrocytomas. In: Kleihues P, Cavenee WK, (Ed). Pathology and Genetics of Tumours of the Nervous System. Lyon: IARC Press 2000:10-21.
13. Hayashi Y, Yamashita J, Yamaguchi K. Timing and role of p53 gene mutation in the recurrence of glioma. Biochem Biophys Res Comm 1991;180:1145-50.
14. Sidransky D, Mikkelson T, Schwehheimer K, et al. Clonal expansion of p53 mutant cell is associated with brain tumor progression. Nature 1992;355:846-7.
15. Iuzzolino P, Ghimenton C, Nicolato A, et al. p53 in low grade astrocytomas: A study with long-term follow-up. Br J Cancer 1994;69:586-91.
16. Sarkar C, Ralte AM, Sharma MC, Mehta VS. Recurrent astrocytic tumours - a study of p53 immunoreactivity and malignant progression. Br J Neurosurg 2002;16:335-42.
17. Kraus JA, Bolln C, Wolf HK, et al. TP53 alterations and clinical outcome in low grade astrocytomas. Genes Chromsomes Cancer 1994;10:143-9.
18. Al Sarraj S, Bridges LR. p53 immunoreactivity in astrocytomas and its relationship to survival. Br J Neurosurg 1995;9:143-9.
19. Pollack IF, Hamilton RL, Finkelstein SD, et al. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res 1997;57:304-9.
20. Hilton DA, Love S, Barber R, et al. Accumulation of p53 and Ki-67 expression do not predict survival of patients with fibrillary astrocytomas or the response of these tumors to radiotherapy. Neurosurg 1998;42:724-9.
21. Burger PC, Scheithauer BW, Paulus W, et al. Pilocytic astrocytoma. In: Kleihues P, Cavenee WK, (Ed). Pathology and genetics of tumors of the nervous system. Lyon: IARC Press 2000:45-51.
22. Lang FF, Miller DC, Pisharody S, et al. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Oncogene 1994;9:949-54.
23. Patt S, Gries H, Giraldo M, et al. p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas. Hum Pathol 1996;27:586-9.
24. Surg T, Miller DC, Hayes RL, et al. Preferential inactivation of p53 tumor suppressor pathway and lack of EGFR amplification distinguish de nova high grade paediatric astrocytomas from de novo adult astrocytomas. Brain Pathol 2000;10:249-59.
25. Cheng Y, Ng HK, Zhang SF, et al. Genetic alterations in pediatric high grade astrocytomas. Human Pathol 1999;30:1284-90.
26. Felix CA, Slave I, Dunn M, et al. p53 gene mutations in pediatric brain tumors. Med Ped Oncol 1995;25:431-6.
27. Litofsky NS, Hinton D, Raffel C. The lack of a role for p53 in astrocytomas in pediatric patients. Neurosurgery 1994;34:967-73.
28. Orellana C, Hermandez-Marti M, Marinez F, et al. Pediatric brain tumors: loss of heterozygosity at 17p and TP53 gene mutations. Cancer Genet Cytogene 1998;102:93-9.
29. Sure U, Ruedi D, Tachibana O, et al. Determination of p53 mutations, EGFR overexpression and loss of p16 expression in pediatric glioblastomas. J Neuropathol Exp Neurol 1997;56:782-9.
30. Zhang S, Feng X, Koga H, et al. p53 gene mutations in pontine gliomas of juvenile onset. Biochem Biophys Res Common 1993;196:851-7.
31. Ohgaki H, eibl RH, Schwab M, Reichel MB, Mariani L, Gehring M, et al. Mutations of the p53 tumor suppressor gene in nonastrocytic human brain tumors. Cancer Res 1993;51:6202-5.
32. Kros JM, Godschalk JJCJ, Krishnadath KK, et al. Expression of p53 in oligodendrogliomas. J Pathol 1993;171:285-90.
33. Barbareschi M, Iuzzolino P, Pennella A, et al. p53 protein expression in central nervous system neoplasms. J Clin Pathol 1992;45:583-6.
34. Hagel C, Krog B, Laas R, et al. Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas. J Exp Clin Cancer Res 1999;18:305-9.
35. Pavelick J, Hlavka V, Poljak M, et al. p53 immunoreactivity in oligodendrogliomas. J Neuro Oncol 1994;22:1-6.
36. Saito A, Nakazato Y. Evaluation of malignant features in oligodendroglial tumors. Clin Neuropathol 1999;18:61-73.
37. Kleihues P, Burger PC, Collins VP, Newcomb EW, Ohgaki H, Caveneee WK. Glioblastoma. In: Kleihues P, Cavenee WK, (Ed). Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press 2000:29-39.
38. Watanabe K, Sato K, Biernat W, et al. Incidence and timing of p53 mutations during astrocytomas progression in patients with multiple biopsies. Clin Cancer Res 1997;3:523-30.
39. Watanabe K, Tachibana O, Sato K, et al. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996;6:217-24.
40. Hayashi Y, Ueki K, Waha A, et al. Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme. Brain Pathol 1997;7:871-5.
41. Ohgaki H, Watanabe K, Peraud A, et al. A case history of glioma progression. Acta Neuropathol (Berl) 1999;97:525-32.
42. Maintz D, Fiedler K, Koopmann J, et al. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997;56:1098-104.
43. Reifenberger J, Ring GU, Gies U, et al. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 1996;55:822-31.
44. Reifenberger G, Kros JM, Burger PC, Louis DN, Collins VP. Oligodendroglioma. In: Kleihues P, Cavenee WK, (Ed). Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC Press 2000:56-61.
45. Pal L, Behari S, Datta N, Gupta R. Role of p53 in the biology of oligodendrogliomas - An immunohistochemical analysis. Brain Pathol 2000;10:570.
46. Sarkar C, Kumar R, Sharma MC, Ralte AM, Singh VP, Sinha S, et al. p53 and EGFR expression in supratentorial glioblastomas of adults: Genetic subsets and correlation with age and clinical outcome. Brain Tumor Pathol.